ANTONIO TAULER: Open Payments
NPI 1851342844 · CORAL GABLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,738 in 144 payments from 14 companies in 2025. Trend: 2023 $2,111 · 2024 $2,199 · 2025 $2,738
Food & beverage: $2,626Education: $111
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 16 | $421 |
| ABBVIE INC. | 24 | $356 |
| Teva Pharmaceuticals USA, Inc. | 15 | $331 |
| Janssen Pharmaceuticals, Inc | 18 | $290 |
| Lundbeck LLC | 14 | $261 |
| Otsuka America Pharmaceutical, Inc. | 14 | $252 |
| Vanda Pharmaceuticals Inc. | 11 | $249 |
| Alkermes, Inc. | 12 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $152 |
| Axsome Therapeutics, Inc. | 7 | $135 |
Products named: COBENFY, REXULTI, VRAYLAR, INVEGA SUSTENNA, AUSTEDO XR, FANAPT, CAPLYTA, ARISTADA.
Industry payments across FL — which companies pay providers there.
